Activation of overexpressed glucagon ‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression

ConclusionsForced expression of GLP ‐1R attenuates prostate cancer cell proliferation by inhibiting cell cycle progressionin  vitro andin  vivo. Therefore, GLP ‐1R activation might be a potential therapy for prostate cancer.

Source: Journal of Diabetes Investigation - April 8, 2020 Category: Endocrinology Authors: Toru Shigeoka, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Tsuyoshi Horikawa, Tomoko Tanaka, Shinichiro Irie, Ryoko Motonaga, Nobuya Hamanoue, Makito Tanabe, Kazuki Nabeshima, Masatoshi Tanaka, Toshihiko Yanase, Daiji Kawanami Tags: Original Article Source Type: research